A study recently reported that decursin displayed anti-inflammatory activity via down-regulation of the TLR4/JNK signaling pathway provoked by PRP4 expression in lipopolysaccharide (LPS)-induced skin cancer (B16–F10) cells [22]. This evidence concerns the gene TLR4 and skin cancer.